YZYBIO-B: VOLUNTARY ANNOUNCEMENT - PHASE II STUDY DATA OF M701 FOR THE TREATMENT OFMALIGNANT ASCITES PRESENTED AT THE 2024 ASCO MEETING

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.